Total raised
$817K
Last: Equity crowdfunding 2022-12
Stage
Seed
Founded
2021
Headcount
1
HQ
Herzliya
Sector
Health Tech & Life Sciences
About
CuratioDL provides cancer management solutions by delivering accurate diagnoses and prognoses, allowing personalized treatment for cancer patients based on deep-learning-powered pathology analysis. This pre-processing segmentation technology will allow pathologists, particularly those who are not necessarily experts in a specific field, to obtain expert-level decision support diagnosis and prognosis. The company has an exclusive patented technology developed at Harvard University. The technology was tested successfully on 10 types of cancer malignancies and showed high validation in diagnosing types and subtypes of cancers.
Funding history · 1 round · $817K total
2022-12
Equity crowdfunding
$317K
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Platforms & InterfacesSoftwareArtificial IntelligenceMachine LearningDeep LearningData StorageCloud
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareInsurance CompaniesLaboratoriesProviders
Business model
B2BB2B2C
Highlights
1 PatentsVerified
Tags
personalizationcloud-basedartificial-intelligencepharma-companiesinsurance-companiesbig-data-analyticsdeep-learningsaasprecision-medicinelaboratoriescancercancer-diagnosticsdigital-healthcareimage-processingdeep-neural-networksdecision-supportdiagnosticshealthcare-providers